Bridge City Capital, LLC Coherus Bio Sciences, Inc. Transaction History

Bridge City Capital, LLC

$359 Million
Q3 2024

A detailed history of Bridge City Capital, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Bridge City Capital, LLC holds 367,305 shares of CHRS stock, worth $539,938. This represents 0.11% of its overall portfolio holdings.

Number of Shares

367,305

Previous 316,009 16.23%

Holding current value

$539,938

Previous $546,000 30.22%

% of portfolio

0.11%

Previous 0.19%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.99 - $1.8 $50,783 - $92,332	51,296 Added 16.23%	367,305 $381,000
Q2 2024 Aug 12, 2024	BUY	$1.58 - $2.51 $987 - $1,568	625 Added 0.2%	316,009 $546,000
Q1 2024 Apr 12, 2024	BUY	$2.02 - $3.14 $4,949 - $7,693	2,450 Added 0.78%	315,384 $753,000
Q4 2023 Feb 13, 2024	BUY	$1.59 - $3.85 $58,368 - $141,333	36,710 Added 13.29%	312,934 $1.04 Million
Q3 2023 Nov 15, 2023	BUY	$3.74 - $5.45 $411,579 - $599,761	110,048 Added 66.22%	276,224 $1.03 Million
Q2 2023 Aug 16, 2023	BUY	$3.79 - $8.3 $341 - $747	90 Added 0.05%	166,176 $709,000
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $3,746 - $6,690	-636 Reduced 0.38%	166,086 $1.14 Million
Q4 2022 Jan 25, 2023	SELL	$5.69 - $10.07 $6,515 - $11,530	-1,145 Reduced 0.68%	166,722 $1.32 Million
Q3 2022 Nov 08, 2022	BUY	$7.17 - $13.87 $41,019 - $79,350	5,721 Added 3.53%	167,867 $1.61 Million
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $1,675 - $3,783	-286 Reduced 0.18%	162,146 $1.17 Million
Q1 2022 May 18, 2022	SELL	$10.92 - $16.41 $8,364 - $12,570	-766 Reduced 0.47%	162,432 $2.1 Million
Q4 2021 Jan 20, 2022	SELL	$15.81 - $18.99 $189 - $227	-12 Reduced 0.01%	163,198 $2.61 Million
Q3 2021 Nov 10, 2021	BUY	$12.68 - $17.79 $60,648 - $85,089	4,783 Added 3.02%	163,210 $2.62 Million
Q2 2021 Aug 11, 2021	SELL	$12.95 - $15.41 $72,545 - $86,326	-5,602 Reduced 3.42%	158,427 $2.19 Million
Q1 2021 Apr 28, 2021	BUY	$14.42 - $21.39 $667,617 - $990,314	46,298 Added 39.33%	164,029 $2.4 Million
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $20,269 - $23,182	-1,224 Reduced 1.03%	117,731 $2.05 Million
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $2.07 Million - $2.37 Million	118,955 New	118,955 $2.18 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $114M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge City Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge City Capital, LLC with notifications on news.

Account

Bridge City Capital, LLC Coherus Bio Sciences, Inc. Transaction History